These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33606067)

  • 1. The prognostic implications of chronic kidney disease and anemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Takeuchi M; Dohi T; Takahashi N; Endo H; Doi S; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Minamino T
    Heart Vessels; 2021 Aug; 36(8):1117-1124. PubMed ID: 33606067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients.
    Matsue Y; Matsumura A; Abe M; Ono M; Seya M; Nakamura T; Iwatsuka R; Mizukami A; Setoguchi M; Nagahori W; Ohno M; Suzuki M; Hashimoto Y
    Heart Vessels; 2013 Jan; 28(1):19-26. PubMed ID: 22160439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of preoperative chronic kidney disease and anemia in patients undergoing coronary artery bypass graft surgery.
    Ogami T; Matsue Y; Kawasumi R; Tanabe H
    Surg Today; 2017 Feb; 47(2):245-251. PubMed ID: 27324394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
    Chernin G; Chen S; Ozan O; Liu M; Haberman D; Perlman G; Ben-Yehuda O; Jonas M
    Am J Nephrol; 2019; 50(6):465-472. PubMed ID: 31655801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Chronic Kidney Disease and Anemia on Outcomes After Percutaneous Coronary Revascularization.
    Cilia L; Sharbaugh M; Marroquin OC; Toma C; Smith C; Thoma F; Lee J; Mulukutla SR
    Am J Cardiol; 2019 Sep; 124(6):851-856. PubMed ID: 31375241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Baber U; Farkouh ME; Arbel Y; Muntner P; Dangas G; Mack MJ; Hamza TH; Mehran R; Fuster V
    Eur Heart J; 2016 Dec; 37(46):3440-3447. PubMed ID: 27572072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Chen H; Spirito A; Sartori S; Nicolas J; Cao D; Zhang Z; Baber U; Kamaleldin K; Guthrie J; Vogel B; Sweeny J; Krishnan P; Sharma SK; Kini A; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2023 Feb; 101(3):511-519. PubMed ID: 36691863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
    Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
    J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial.
    Milojevic M; Head SJ; Mack MJ; Mohr FW; Morice MC; Dawkins KD; Holmes DR; Serruys PW; Kappetein AP
    EuroIntervention; 2018 May; 14(1):102-111. PubMed ID: 29155387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
    Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease.
    Tokuda K; Tanaka A; Tobe A; Shirai Y; Kurobe M; Kubota Y; Kunieda T; Miyazaki T; Mizutani K; Furusawa K; Ishii H; Murohara T
    J Atheroscler Thromb; 2023 Nov; 30(11):1635-1643. PubMed ID: 36908149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Plasma Lipoprotein(a) With Long-Term Adverse Events in Patients With Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
    Xu N; Tang XF; Yao Y; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Am J Cardiol; 2018 Dec; 122(12):2043-2048. PubMed ID: 30477725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention.
    Lin MJ; Yang WC; Chen CY; Huang CC; Chuang HY; Gao FX; Wu HP
    Sci Rep; 2018 Dec; 8(1):17673. PubMed ID: 30518771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical impact of serum albumin in coronary artery disease patients with preserved renal function.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):285-290. PubMed ID: 29289574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
    Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
    Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention.
    Wang X; Zhao J; Wang H; Zhao Y; Fu X
    Ir J Med Sci; 2021 Feb; 190(1):89-96. PubMed ID: 32529544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of sex, body mass index and chronic kidney disease on outcomes following percutaneous coronary intervention.
    Bimal T; Bhuiyan MR; Fishbein J; Ukrani J; Gandotra P; Selim S; Ong L; Gruberg L
    Cardiovasc Revasc Med; 2024 Feb; 59():37-45. PubMed ID: 37604707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.